STEPHANIE PRATHER: Open Payments
NPI 1336758846 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 47 payments from 10 companies in 2025. Trend: 2023 $338 · 2024 $637 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $213 |
| ABBVIE INC. | 6 | $149 |
| AstraZeneca Pharmaceuticals LP | 4 | $137 |
| PFIZER INC. | 6 | $130 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Rybelsus, VRAYLAR, Ozempic, BREZTRI, ELIQUIS, PREVNAR 20, UBRELVY, TRELEGY ELLIPTA.
Industry payments across NV — which companies pay providers there.
